4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ANI Pharmaceuticals, Inc. (ANIP) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Baudette, United States with about 970 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, ANIP reported $883M in revenue and $78M in net income.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
Interactive charts & full statements → Open the ANIP valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $883M | $614M | $487M | $316M | — |
| Gross Profit | $542M | $364M | $305M | $178M | — |
| Operating Income (EBIT) | $81M | $2M | $50M | ($26M) | — |
| Net Income | $78M | ($18M) | $19M | ($48M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $238M | $247M | $228M | $211M | $197M | — |
| Gross Profit | $144M | $147M | $134M | $137M | $124M | — |
| Operating Income (EBIT) | $39M | $29M | $23M | $15M | $14M | — |
| Net Income | $30M | $28M | $27M | $8M | $16M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | ($1M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | ($0M) | ($0M) | ($0M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.4B | $1.3B | $904M | $760M | — |
| Total Liabilities | $900M | $856M | $447M | $422M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ANIP viewer.
About TickerBase · Data methodology & sources